Business Segment Information (Tables)

3 Months Ended

Mar. 31, 2012

Business Segments

Schedule of Segment Reporting Information, by Segment [Table Text Block]

			Three Months Ended
			March 31,		April 2,
(In millions)			2012			2011
Revenues
	Analytical Technologies		$	1,006.2		$	830.2
	Specialty Diagnostics			729.4			576.6
	Laboratory Products and Services			1,506.7			1,442.5
	Eliminations			(142.0)			(127.9)
		Consolidated revenues		3,100.3			2,721.4
Segment Income
	Analytical Technologies (a)			185.3			137.0
	Specialty Diagnostics (a)			186.0			141.9
	Laboratory Products and Services (a)			201.7			199.3
		Subtotal reportable segments (a)		573.0			478.2
	Cost of revenues charges			(26.8)			(2.9)
	Selling, general and administrative income (charges), net			7.7			(3.1)
	Restructuring and other costs, net			(15.1)			(15.3)
	Amortization of acquisition-related intangible assets			(183.9)			(135.4)
		Consolidated operating income		354.9			321.5
	Other expense, net (b)			(49.9)			(22.5)
	Income from continuing operations before provision for income taxes		$	305.0		$	299.0
Depreciation
	Analytical Technologies		$	16.7		$	13.5
	Specialty Diagnostics			17.7			9.7
	Laboratory Products and Services			25.5			25.7
		Consolidated depreciation	$	59.9		$	48.9
(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)	The company does not allocate other expense, net to its segments.

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

			Three Months Ended
			March 31,		April 2,
(In millions)			2012			2011
Revenues
	Analytical Technologies		$	1,006.2		$	830.2
	Specialty Diagnostics			729.4			576.6
	Laboratory Products and Services			1,506.7			1,442.5
	Eliminations			(142.0)			(127.9)
		Consolidated revenues		3,100.3			2,721.4
Segment Income
	Analytical Technologies (a)			185.3			137.0
	Specialty Diagnostics (a)			186.0			141.9
	Laboratory Products and Services (a)			201.7			199.3
		Subtotal reportable segments (a)		573.0			478.2
	Cost of revenues charges			(26.8)			(2.9)
	Selling, general and administrative income (charges), net			7.7			(3.1)
	Restructuring and other costs, net			(15.1)			(15.3)
	Amortization of acquisition-related intangible assets			(183.9)			(135.4)
		Consolidated operating income		354.9			321.5
	Other expense, net (b)			(49.9)			(22.5)
	Income from continuing operations before provision for income taxes		$	305.0		$	299.0
Depreciation
	Analytical Technologies		$	16.7		$	13.5
	Specialty Diagnostics			17.7			9.7
	Laboratory Products and Services			25.5			25.7
		Consolidated depreciation	$	59.9		$	48.9
(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)	The company does not allocate other expense, net to its segments.